Our medical and scientific team continues research to improve therapies and offer additional
treatment options. Contact a BioXcellerator Patient Advocate to see if new treatments are
available for your condition.
BioXcellerator to Present Breakthrough MSC Research at ISCT 2025 in New Orleans
BioXcellerator is proud to participate in ISCT 2025, the leading global forum for advancing cell and gene therapy. Join us in New Orleans as we connect with innovators, researchers, and healthcare leaders shaping the future of regenerative medicine.
Stop by our posters to learn more about how BioXcellerator is redefining stem cell science with advanced mesenchymal stem cell (MSC) technologies, personalized protocols, and real-world patient outcomes. From orthopedic recovery to autoimmune care, we’re advancing therapies that promote healing where traditional medicine has fallen short.
Why Visit BioXcellerator at ISCT?
Explore our next-generation MSC protocols and lab capabilities
Learn how we’re supporting clinicians and researchers across borders
Discover partnership and referral opportunities
Meet our clinical and research teams
Get a sneak peek at upcoming clinical collaborations and case studies
Meet the Experts Driving Innovation. Our ISCT presenters include:
Medical Director, BioXcellerator Emergency physician
Poster: Mesenchymal Stem Cell Therapy in Patients with Diabetes: A Comprehensive Systematic Review
Poster ID: 4281868
Why ISCT Matters to BioXcellerator
This moment isn’t just about showcasing our science—it’s about creating new connections that will shape the future of regenerative medicine. BioXcellerator is actively seeking healthcare providers, clinical researchers, and strategic partners to join our growing global network.
Whether you’re a researcher, clinician, or healthcare decision-maker, we welcome the opportunity to connect and explore areas of shared interest and impact.
Let’s Connect
Will you be in New Orleans for ISCT 2025? Let’s talk. Reach out to our team to schedule a meeting or learn more about our latest clinical and research initiatives.